HCP, Inc. (HCP) Expected to Post Earnings of $0.43 Per Share

Share on StockTwits

Equities research analysts predict that HCP, Inc. (NYSE:HCP) will announce earnings per share (EPS) of $0.43 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for HCP’s earnings, with the highest EPS estimate coming in at $0.44 and the lowest estimate coming in at $0.42. HCP reported earnings per share of $0.47 during the same quarter last year, which would suggest a negative year-over-year growth rate of 8.5%. The company is scheduled to report its next earnings results on Thursday, August 1st.

According to Zacks, analysts expect that HCP will report full-year earnings of $1.73 per share for the current fiscal year, with EPS estimates ranging from $1.71 to $1.75. For the next year, analysts expect that the business will report earnings of $1.80 per share, with EPS estimates ranging from $1.75 to $1.85. Zacks’ earnings per share averages are a mean average based on a survey of research firms that that provide coverage for HCP.

HCP (NYSE:HCP) last issued its quarterly earnings data on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.01. HCP had a return on equity of 18.05% and a net margin of 59.96%. The company had revenue of $436.15 million for the quarter, compared to the consensus estimate of $442.20 million. During the same quarter last year, the business posted $0.48 earnings per share. The firm’s revenue was down 9.0% compared to the same quarter last year.

HCP has been the topic of a number of research reports. BMO Capital Markets restated a “buy” rating and set a $33.00 price target on shares of HCP in a research report on Wednesday, February 13th. TheStreet upgraded HCP from a “c” rating to a “b-” rating in a research report on Wednesday, February 13th. Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a research report on Thursday, March 14th. Finally, Morgan Stanley set a $32.00 price target on HCP and gave the company a “hold” rating in a research report on Thursday, March 28th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $28.95.

In other news, Director Christine Garvey sold 3,405 shares of HCP stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $29.80, for a total transaction of $101,469.00. Following the completion of the transaction, the director now directly owns 5,348 shares in the company, valued at $159,370.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.13% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in HCP. Deutsche Bank AG lifted its holdings in shares of HCP by 1,073.7% during the fourth quarter. Deutsche Bank AG now owns 10,704,554 shares of the real estate investment trust’s stock valued at $298,971,000 after purchasing an additional 9,792,507 shares during the last quarter. Zimmer Partners LP purchased a new position in shares of HCP during the fourth quarter valued at approximately $230,959,000. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in shares of HCP by 73.8% during the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,036,864 shares of the real estate investment trust’s stock valued at $392,050,000 after purchasing an additional 5,960,734 shares during the last quarter. Cohen & Steers Inc. lifted its holdings in shares of HCP by 35.0% during the fourth quarter. Cohen & Steers Inc. now owns 22,898,362 shares of the real estate investment trust’s stock valued at $639,551,000 after purchasing an additional 5,935,752 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of HCP during the fourth quarter valued at approximately $128,473,000. Hedge funds and other institutional investors own 96.95% of the company’s stock.

Shares of HCP stock opened at $30.88 on Monday. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.90. HCP has a 52-week low of $22.49 and a 52-week high of $32.23. The firm has a market capitalization of $14.79 billion, a P/E ratio of 16.97, a price-to-earnings-growth ratio of 6.73 and a beta of 0.43.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 21st. Investors of record on Monday, May 6th will be paid a $0.37 dividend. The ex-dividend date is Friday, May 3rd. This represents a $1.48 annualized dividend and a dividend yield of 4.79%. HCP’s payout ratio is presently 81.32%.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Further Reading: Why do companies issue convertible shares?

Get a free copy of the Zacks research report on HCP (HCP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.